Cardiovascular Drugs Practice Questions

Q: Which of the following drugs should be avoided in a pregnant female with dilated cardiomyopathy?

ACE inhibitors. **Explanation:** **ACE inhibitors (ACEIs)** are strictly contraindicated in pregnancy (Category D) due to their significant **teratogenic potential**. While they are first-line agents for dilated cardiomyopathy (DCM) in non-pregnant patients, they must be avoided during pregnancy. Their use, particularly in the second and third trimesters, leads to **fetal renal dysgenesis**, which causes oligohydramnios. This lack of amniotic fluid results in the "Potter sequence" (pulmonary hypoplasia, limb deformities, and cranial facial abnormalities) and fetal skull hypoplasia. **Analysis of Incorrect Options:** * **Beta-blockers:** These are generally considered safe and are often used to manage DCM and arrhythmias in pregnancy. While they may be associated with fetal growth restriction (IUGR) or neonatal hypoglycemia, they are not contraindicated. * **Digoxin:** It is considered safe during pregnancy (Category C) and is the drug of choice for controlling ventricular rate in pregnant patients with heart failure or atrial fibrillation. * **Calcium Channel Blockers (CCBs):** While not first-line for DCM, drugs like Nifedipine are frequently used in pregnancy for hypertension or as tocolytics and are not teratogenic. **High-Yield Clinical Pearls for NEET-PG:** * **Management of DCM in Pregnancy:** The preferred regimen includes **Hydralazine and Nitrates** (as a substitute for ACEIs/ARBs), along with **Digoxin** and **Diuretics** (used cautiously). * **ACEI Fetopathy:** Characterized by renal failure, hypotension, and skull hypoplasia. * **Other Contraindicated Drugs in Pregnancy:** Warfarin (Fetal Warfarin Syndrome), Phenytoin (Fetal Hydantoin Syndrome), Tetracyclines (discolored teeth), and Isotretinoin (severe craniofacial defects).

Q: Clevidipine is a type of which drug class?

Calcium Channel Blocker. **Clevidipine** is a third-generation, ultra-short-acting **Dihydropyridine (DHP) Calcium Channel Blocker (CCB)** [1, 2]. It works by inhibiting the L-type calcium channels in vascular smooth muscle, leading to potent peripheral vasodilation and a rapid reduction in blood pressure without affecting myocardial contractility or venous capacitance [1].**Why the other options are incorrect:** * **ACE Inhibitors (e.g., Enalapril):** These inhibit the conversion of Angiotensin I to Angiotensin II. They are characterized by the suffix "-pril" and are not chemically related to DHPs.* **Alpha Blockers (e.g., Prazosin):** These block alpha_1-adrenergic receptors to cause vasodilation [2]. They do not act on calcium channels.* **ARBs (e.g., Telmisartan):** These block the AT_1 receptor directly. They are characterized by the suffix "-sartan."**High-Yield Clinical Pearls for NEET-PG:** * **Pharmacokinetics:** Clevidipine is unique because it is metabolized by **blood and tissue esterases**, making its clearance independent of renal or hepatic function.* **Half-life:** It has an extremely short half-life (approx. **1 minute**), allowing for rapid titration and quick offset of action.* **Clinical Use:** It is primarily used for the management of **Hypertensive Emergencies** and perioperative blood pressure control.* **Formulation:** It is administered as a **lipid emulsion** (similar to Propofol); therefore, it is contraindicated in patients with severe disorders of lipid metabolism (e.g., pathological hyperlipidemia) or allergies to soy/eggs.

Q: All of the following drugs can worsen angina, except:

Oxyphedrine. **Explanation:** The core concept behind this question is the **"Coronary Steal Phenomenon"** and the myocardial oxygen supply-demand balance. **Why Oxyphedrine is the correct answer:** Oxyphedrine is a unique drug used in the treatment of angina. It acts as a **partial beta-agonist** and has a direct metabolic effect on the myocardium. Unlike potent vasodilators, it improves myocardial metabolism and increases coronary blood flow without causing "coronary steal." Therefore, it is used to *treat* angina rather than worsen it. **Why the other options are incorrect:** * **Dipyridamole:** This is a potent arteriolar dilator. In patients with coronary artery disease, it dilates healthy vessels, "stealing" blood flow away from the already maximally dilated, ischemic distal vessels (the **Coronary Steal Phenomenon**). This worsens ischemia. * **Thyroxine:** It increases the metabolic rate and upregulates beta-receptors in the heart. This leads to increased heart rate and contractility, significantly raising **myocardial oxygen demand**, which can precipitate an anginal attack. * **Sumatriptan:** As a 5-HT$_{1B/1D}$ agonist used for migraines, it can cause **coronary vasospasm**. It is strictly contraindicated in patients with known ischemic heart disease (Prinzmetal or stable angina). **High-Yield NEET-PG Pearls:** * **Coronary Steal Phenomenon:** Classically associated with Dipyridamole and Hydralazine. * **Drugs causing Vasospasm:** Sumatriptan, Ergotamine, and Cocaine. * **Oxyphedrine:** Often classified as a "myocardial enhancer" or "coronary dilator" that is safe in chronic stable angina. * **Thyrotoxicosis:** Always consider it as a secondary cause of worsening angina or new-onset Atrial Fibrillation in elderly patients.

Q: All of the following statements about Ranolazine are true, except?

Hypotension is an established adverse effect.. **Explanation:** **Ranolazine** is a novel antianginal agent with a unique mechanism of action. The correct answer is **D** because, unlike traditional antianginals (Nitrates, Beta-blockers, CCBs), **Ranolazine does not significantly affect heart rate or blood pressure.** Therefore, hypotension is not an established adverse effect. **Breakdown of Options:** * **Option A (True):** Ranolazine is chemically a **piperazine derivative**. It works by inhibiting the **late inward sodium current ($I_{Na}$)** in myocardial cells. This prevents calcium overload via the $Na^+/Ca^{2+}$ exchanger, improving diastolic relaxation and subendocardial perfusion without altering hemodynamics. * **Option B (True):** According to recent guidelines, Ranolazine is approved as a **first-line agent** for chronic stable angina, either as monotherapy or in combination with other drugs. * **Option C (True):** Clinical trials (like CARISA and MERLIN-TIMI 36) have shown that Ranolazine can **reduce HbA1c levels** in diabetic patients, making it a preferred choice for anginal patients with comorbid Diabetes Mellitus. **High-Yield Clinical Pearls for NEET-PG:** * **ECG Change:** Ranolazine causes **dose-dependent QT interval prolongation** (via inhibition of $I_{Kr}$), yet it paradoxically has a low risk of Torsades de Pointes. * **Metabolism:** It is primarily metabolized by **CYP3A4**; hence, it is contraindicated with potent inhibitors like Ketoconazole or Clarithromycin. * **Side Effects:** Most common side effects include dizziness, headache, constipation, and nausea. * **Key Benefit:** It is the drug of choice for angina patients who have low baseline blood pressure or heart rate, as it does not lower them further.

Q: What is the mechanism of action of Nitric oxide?

cGMP. **Mechanism of Action of Nitric Oxide (NO)** **Explanation of the Correct Answer (A):** Nitric Oxide (NO) is a potent endogenous vasodilator and a gaseous signaling molecule. It acts via the **cGMP (cyclic Guanosine Monophosphate) pathway**. 1. NO is released from vascular endothelial cells and diffuses into adjacent smooth muscle cells. 2. It activates the enzyme **soluble Guanylyl Cyclase (sGC)**. 3. This enzyme converts GTP into **cGMP**. 4. Increased cGMP activates Protein Kinase G (PKG), leading to dephosphorylation of myosin light chains and sequestration of intracellular calcium, resulting in **smooth muscle relaxation (vasodilation)**. **Why Other Options are Incorrect:** * **B. cAMP:** This is the second messenger for drugs like Beta-agonists (e.g., Salbutamol) and Prostacyclin ($PGI_2$). While it also causes vasodilation, it is not the primary pathway for NO. * **C. Ca++:** Nitric oxide actually works by *decreasing* intracellular calcium levels to cause relaxation. Increased calcium is typically associated with muscle contraction. * **D. Tyrosine:** This refers to Tyrosine Kinase receptors, which are utilized by insulin and various growth factors, not by gaseous signaling molecules like NO. **High-Yield Clinical Pearls for NEET-PG:** * **Nitrates (Nitroglycerin):** Act as prodrugs that are metabolized to release NO, utilizing this same cGMP pathway to relieve angina. * **PDE-5 Inhibitors (Sildenafil):** These drugs inhibit the breakdown of cGMP. Since NO increases cGMP, Sildenafil potentiates NO-mediated vasodilation (used in Erectile Dysfunction and Pulmonary Hypertension). * **Inhaled NO:** Used clinically in the management of Persistent Pulmonary Hypertension of the Newborn (PPHN). * **EDRF:** Nitric Oxide was formerly known as Endothelium-Derived Relaxing Factor.

Q: Nesiritide is broken down by which enzyme?

Endopeptidase. **Explanation:** **Nesiritide** is a recombinant form of human **B-type Natriuretic Peptide (BNP)**. It is used in the management of acutely decompensated heart failure to reduce pulmonary capillary wedge pressure and improve dyspnea through its potent vasodilatory and natriuretic effects. 1. **Why Endopeptidase is correct:** Nesiritide, being a peptide, is primarily cleared from the circulation via two mechanisms: binding to natriuretic peptide receptors (NPR-C) followed by cellular internalization, and enzymatic degradation. The specific enzyme responsible for its proteolytic cleavage is **Neutral Endopeptidase (NEP)**, also known as **Neprilysin**. This enzyme breaks the peptide bonds of various endogenous vasoactive peptides, including BNP, ANP, and bradykinin. 2. **Why the other options are incorrect:** * **Angiotensin-converting enzyme (ACE):** While ACE is a peptidyl dipeptidase, its primary role is converting Angiotensin I to Angiotensin II and inactivating bradykinin. It does not play a significant role in the metabolism of BNP. * **Vasopeptidase:** This is not a single enzyme but a class of drugs (e.g., Omapatrilat) that inhibits both ACE and Neutral Endopeptidase. * **Amidase:** These enzymes catalyze the hydrolysis of an amide or peptide bond but are typically associated with the metabolism of drugs like lidocaine or certain prodrugs, not the physiological degradation of natriuretic peptides. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Nesiritide increases intracellular **cGMP**, leading to smooth muscle relaxation. * **Clinical Use:** Used in **Acute Decompensated Heart Failure (ADHF)** with dyspnea at rest. * **Major Side Effect:** Dose-related **hypotension** is the most common adverse effect. * **Related Drug:** **Sacubitril** is a Neprilysin inhibitor used in HFrEF (combined with Valsartan as ARNI) to prevent the breakdown of endogenous BNP.

Question 1

What is the antihypertensive of choice for a patient with hypertension, diabetes mellitus, and proteinuria?

Accepted Answer

Alpha-methyldopa

Answer

Propranolol

Answer

Clonidine

Answer

Enalapril

Question 2

Which of the following drugs should be avoided in a pregnant female with dilated cardiomyopathy?

Accepted Answer

ACE inhibitors

Answer

Beta blockers

Answer

Digoxin

Answer

Calcium channel blockers

Question 3

Clevidipine is a type of which drug class?

Accepted Answer

Calcium Channel Blocker

Answer

Angiotensin-Converting Enzyme Inhibitor (ACEI)

Answer

Alpha Blocker

Answer

Angiotensin Receptor Blocker (ARB)

Question 4

All of the following drugs can worsen angina, except:

Accepted Answer

Oxyphedrine

Answer

Dipyridamole

Answer

Thyroxine

Answer

Sumatriptan

Question 5

Septicemic shock with multi-organ failure is treated by which of the following medications?

Accepted Answer

Norepinephrine

Answer

Adrenaline

Answer

Ephedrine

Answer

Phenylephrine

Question 6

All of the following statements about Ranolazine are true, except?

Accepted Answer

Hypotension is an established adverse effect.

Answer

Piperazine derived antianginal agent.

Answer

May be used as first line agent in chronic angina.

Answer

May improve glycemic control.

Question 7

Which drug is contraindicated in severe hypertriglyceridemia?

Accepted Answer

Niacin

Answer

Fibrates

Answer

Simvastatin

Answer

Cholestyramine

Question 8

What is the mechanism of action of Nitric oxide?

Accepted Answer

cGMP

Answer

cAMP

Answer

Ca++

Answer

Tyrosine

Question 9

Nesiritide is broken down by which enzyme?

Accepted Answer

Endopeptidase

Answer

Angiotensin converting enzyme

Answer

Vasopeptidase

Answer

Amidase

Question 10

Which of the following drugs is capable of maintaining blood levels for 24 hours after a single administration but has useful antianginal effects lasting only about 10 hours?

Accepted Answer

Nitroglycerine (transdermal)

Answer

Amyl nitrite

Answer

Isosorbide mononitrate

Answer

Nitroglycerine (sublingual)

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?